CERE
Cerevel Therapeutics Holdings, Inc.
CEO and Chair N Anthony Coles sold $1.3M of Cerevel Therapeutics Holdings, Inc.
Sold$1,253,130
$25.06Price
50,000Shares
−95%Stake
What CERE did after the filing
- The stock from Thu, Apr 13 close, $25.50
- +27.7%
- S&P 500, same days
- +0.3%
Measured over 30 trading days, to the May 25 close.
Traded Tue, Apr 11. Filed Thu, Apr 13, 12:48 PM ET, during the session. Returns use the Apr 13 close and the May 25 close. Not investment advice.